Headlines Expert Newsletters Covid-19 Specialties Trending Feeds Videos

‎Show In Machines We Trust, Ep The AI in the newsroom – Feb 7,...

‎Show Reimagine Hybrid Work, Ep S2. #28 Mitel’s Nagaswamy Talks About The Changes in Communications for Distributed Work – Feb 7,...

‎Show THE MCCULLOUGH REPORT, Ep Mind-Blowing Reality of Death after Injection – Feb 6,...

Mashup Score:2

Apple Podcasts

‎Science ·...

‎Show Unraveled, Ep BCL-2 Inhibitors: Driving Cells to Destruction – Jan 31,...

  • 1623048956392374276 Profile photo of Madelyn

    The story behind Venetoclax, a new cancer therapy, started nearly 40 years ago. How it went from the discovery of a protein to a game changing cancer drug is a story of persistence and momentum, and the first episode of season two of the Unraveled podcast https://t.co/hgSujTZijb - view on twitter

‎Show Healthcare Unfiltered, Ep BTK-Inhibitor Development: A Researcher’s Perspective – Feb 7,...

‎Show AMA STEPS Forward® podcast, Ep The Importance of Screening for Social Determinants of Health – Feb 1,...

‎Show In the Bubble with Andy Slavitt, Ep Andy Talks to ChatGPT, a Congressman, and an Expert about AI – Feb 6,...

‎Show Unraveled, Ep BCL-2 Inhibitors: Driving Cells to Destruction – Jan 31,...

  • 1622626171870388225 Profile photo of Madelyn

    “There was incredible science, but there was a skepticism that we could ever target that pathway therapeutically. Because of some of the prior drugs that had tried and failed.” @DrMDavids on the story of Bcl-2 on Unraveled, a Dana-Farber podcast. https://t.co/hgSujTZijb - view on twitter